(2S)-2-isocyanato-3-methylbutane → HCID 49779768, Verbindung
Reaktionsgleichung
[N:1]([C@H:4]([CH:6]([CH3:8])[CH3:7])[CH3:5])=[C:2]=[O:3].Cl.[CH3:10][N:11]1[CH2:16][CH2:15][N:14]([C:17]2[CH:22]=[C:21]([C:23]3[CH:32]=[C:31]4[C:26]([CH2:27][CH2:28][NH:29][CH2:30]4)=[CH:25][CH:24]=3)[N:20]=[C:19]([NH2:33])[N:18]=2)[CH2:13][CH2:12]1>>[NH2:33][C:19]1[N:20]=[C:21]([C:23]2[CH:32]=[C:31]3[C:26]([CH2:27][CH2:28][N:29]([C:2]([NH:1][C@@H:4]([CH3:5])[CH:6]([CH3:8])[CH3:7])=[O:3])[CH2:30]3)=[CH:25][CH:24]=2)[CH:22]=[C:17]([N:14]2[CH2:13][CH2:12][N:11]([CH3:10])[CH2:16][CH2:15]2)[N:18]=1Komponenten
3
Versuchsvorschrift
This compound was prepared by using procedures analogous to those described for the synthesis of Example 5 starting from (2S)-2-isocyanato-3-methylbutane (Alfa Aesar, Cat. #L20354) and 4-(4-methylpiperazin-1-yl)-6-(1,2,3,4-tetrahydroisoquinolin-7-yl)pyrimidin-2-amine HCl salt. Analytic LCMS (M+H)+: m/z=438.3.
Aufarbeitung
- customThis compound was prepared